<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="kennedy" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">kennedy</book-part-id>
      <title-group>
        <title>Spinal and Bulbar Muscular Atrophy</title>
        <alt-title alt-title-type="alt-title">Synonyms: Kennedy&#x02019;s Disease, SBMA, X-Linked Spinal and Bulbar Muscular Atrophy</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>La Spada</surname>
            <given-names>Albert</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>University of California, San Diego School of Medicine<break/>La Jolla, California</aff>
          <email>alaspada@ucsd.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>26</day>
          <month>2</month>
          <year>1999</year>
        </date>
        <date date-type="updated">
          <day>26</day>
          <month>1</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="spg11" document-type="chapter">Spastic Paraplegia 11</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="sma" document-type="chapter">Spinal Muscular Atrophy</related-object>
      <abstract id="kennedy.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Spinal and bulbar muscular atrophy (SBMA) is a gradually progressive neuromuscular disorder in which degeneration of lower motor neurons results in muscle weakness, muscle atrophy, and fasciculations. SBMA occurs only in males. Affected individuals often show gynecomastia, testicular atrophy, and reduced fertility as a result of mild androgen insensitivity.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of SBMA is established in a male proband by the identification of a hemizygous expansion of a CAG trinucleotide repeat (&#x0003e;35 CAGs) in <italic toggle="yes">AR</italic> by molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Use of braces and walkers for ambulation as needed as the disease progresses; breast reduction surgery for gynecomastia as needed.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual assessment of strength; annual assessment of pulmonary function in advanced cases.</p>
          <p><italic toggle="yes">Other:</italic> Clinical trials of anti-androgen drugs (e.g., leuprorelin) did not reveal significant efficacy. Based on animal studies, administration of testosterone and its analogs may make the motor neuron disease worse.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>SBMA is inherited in an X-linked manner. Affected males who are fertile pass the expanded CAG repeat to each daughter. Carrier females have a 50% chance of transmitting the CAG trinucleotide expansion to each child; males who inherit it will be affected; females who inherit it will be carriers and will not be affected. Carrier testing for at-risk female relatives and prenatal testing for pregnancies at increased risk are possible if the expanded CAG repeat has been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="kennedy.Diagnosis">
        <title>Diagnosis</title>
        <sec id="kennedy.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Spinal and bulbar muscular atrophy (SBMA) <bold>should be suspected</bold> in males with the following clinical features and family history.</p>
          <p>
            <bold>Clinical features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Adolescent-onset signs of androgen insensitivity (e.g., gynecomastia)</p>
            </list-item>
            <list-item>
              <p>Post-adolescent onset of:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Spinal lower motor neuron disease with muscle weakness of the limbs or muscle cramps</p>
                </list-item>
                <list-item>
                  <p>Bulbar lower motor neuron disease with fasciculations of the tongue, lips, or perioral region; dysarthria and difficulty swallowing</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>No signs of upper motor neuron disease (e.g., hyperreflexia, spasticity)</p>
            </list-item>
          </list>
          <p>
            <bold>Family history</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Consistent with X-linked inheritance</p>
            </list-item>
            <list-item>
              <p>Note: Lack of a family history consistent with X-linked inheritance does not preclude the diagnosis.</p>
            </list-item>
          </list>
        </sec>
        <sec id="kennedy.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of SBMA <bold>is established</bold> in a male proband by the identification of a hemizygous expansion of a CAG trinucleotide repeat (&#x0003e;35 CAGs) in <italic toggle="yes">AR</italic> by molecular genetic testing (see <xref ref-type="table" rid="kennedy.T.molecular_genetic_testing_used">Table 1</xref>).</p>
          <p><bold>Allele sizes.</bold> All individuals with SBMA have an expansion in the number of CAG trinucleotide repeats in exon 1 of <italic toggle="yes">AR</italic>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Normal alleles.</bold> 34 or fewer CAG trinucleotide repeats</p>
            </list-item>
            <list-item>
              <p><bold>Mutable normal alleles.</bold> None reported to date</p>
            </list-item>
            <list-item>
              <p><bold>Reduced-penetrance alleles.</bold>
<xref ref-type="bibr" rid="kennedy.REF.kuhlenb_umer.2001.23">Kuhlenb&#x000e4;umer et al [2001]</xref> suggested that an allele of 37 CAG trinucleotide repeats can manifest reduced penetrance. Therefore, the clinical significance of alleles with 36-37 CAG repeats should be interpreted within the context of family history, the consultand's clinical presentation, and genotype-phenotype correlations in other family members.</p>
            </list-item>
            <list-item>
              <p><bold>Full-penetrance alleles.</bold> 38 or more CAG trinucleotide repeats</p>
            </list-item>
            <list-item>
              <p><bold>Alleles of questionable significance.</bold> There is no consensus as to the clinical significance of alleles of 35 CAG repeats. Interpretation of alleles of this size may require consideration of the affected individual's clinical presentation and reconciliation with repeat sizes in family members.</p>
            </list-item>
          </list>
          <p>Molecular genetic testing approaches include <bold>targeted testing</bold> for the CAG repeat size in <italic toggle="yes">AR</italic>.</p>
          <table-wrap id="kennedy.T.molecular_genetic_testing_used" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Spinal and Bulbar Muscular Atrophy</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_kennedy.T.molecular_genetic_testing_used_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_kennedy.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_kennedy.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_kennedy.T.molecular_genetic_testing_used_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">AR</italic>
                  </td>
                  <td headers="hd_h_kennedy.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_kennedy.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="kennedy.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="kennedy" object-id="kennedy.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="kennedy.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="kennedy.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="kennedy.TF.1.3">
                <label>3. </label>
                <p>CAG repeat number can be determined by fragment length analysis of amplicons from polymerase chain reaction (PCR) amplification of the CAG repeat region within AR.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="kennedy.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="kennedy.Clinical_Description">
          <title>Clinical Description</title>
          <p>Spinal and bulbar muscular atrophy (SBMA, or Kennedy's disease, named for the neurologist who published an early clinical description) is a disorder of slowly progressive muscle weakness associated with mild androgen insensitivity [<xref ref-type="bibr" rid="kennedy.REF.kennedy.1968.671">Kennedy et al 1968</xref>, <xref ref-type="bibr" rid="kennedy.REF.harding.1982.1012">Harding et al 1982</xref>]. Only males are affected.</p>
          <p><bold>Neurologic findings.</bold> Neurologic symptoms typically begin between age 30 and 50 years [<xref ref-type="bibr" rid="kennedy.REF.atsuta.2006.1446">Atsuta et al 2006</xref>, <xref ref-type="bibr" rid="kennedy.REF.rhodes.2009.3242">Rhodes et al 2009</xref>]. Onset of neurologic symptoms does not usually occur in childhood or adolescence.</p>
          <p>Early signs are difficulty with walking and a tendency to fall. Many individuals have muscle cramps, while others complain of an action tremor [<xref ref-type="bibr" rid="kennedy.REF.grunseich.2014b.6">Grunseich et al 2014b</xref>]. Deep tendon reflexes are decreased.</p>
          <p>After one to two decades of symptoms, most affected individuals have difficulty climbing stairs. With time, atrophy of the proximal and distal musculature becomes evident. About one third of affected individuals require a wheelchair 20 years after the onset of symptoms.</p>
          <p>Most individuals eventually show involvement of the bulbar muscles and have difficulty with speech articulation and swallowing. Severely affected individuals (many of whom are non-ambulatory) are at risk for aspiration pneumonia and ventilatory failure because of weakness of the bulbar and respiratory musculature [<xref ref-type="bibr" rid="kennedy.REF.mariotti.2000.391">Mariotti et al 2000</xref>, <xref ref-type="bibr" rid="kennedy.REF.atsuta.2006.1446">Atsuta et al 2006</xref>]. This complication is the main life-threatening problem in SBMA, and likely becomes an issue for only a minority of individuals. Therefore, the majority of individuals with SBMA have a normal life expectancy and do not die from direct complications of their motor neuron disease. Fifteen of 223 persons in the <xref ref-type="bibr" rid="kennedy.REF.atsuta.2006.1446">Atsuta et al [2006]</xref> study died at a mean age of 65 years.</p>
          <p>Affected males may also have degeneration of the dorsal root ganglia, leading to mild (usually subclinical) abnormalities in sensory function in the distal extremities [<xref ref-type="bibr" rid="kennedy.REF.antonini.2000.252">Antonini et al 2000</xref>, <xref ref-type="bibr" rid="kennedy.REF.grunseich.2014b.6">Grunseich et al 2014b</xref>].</p>
          <p><bold>Electrodiagnostic studies</bold> are consistent with diffuse denervation atrophy, anterior horn cell loss, and sensory neuronopathy [<xref ref-type="bibr" rid="kennedy.REF.olney.1991.823">Olney et al 1991</xref>, <xref ref-type="bibr" rid="kennedy.REF.ferrante.1997.323">Ferrante &#x00026; Wilbourn 1997</xref>].</p>
          <p><bold>Histopathology.</bold> Degeneration of anterior horn cells in the spinal cord of affected individuals is observed [<xref ref-type="bibr" rid="kennedy.REF.kennedy.1968.671">Kennedy et al 1968</xref>, <xref ref-type="bibr" rid="kennedy.REF.amato.1993.791">Amato et al 1993</xref>, <xref ref-type="bibr" rid="kennedy.REF.ogata.1994.1274">Ogata et al 1994</xref>]. Changes in muscle include evidence of myopathy [<xref ref-type="bibr" rid="kennedy.REF.sorar_.2008.100">Sorar&#x000f9; et al 2008</xref>], in addition to neurogenic muscle atrophy. Immunohistochemistry shows inclusions of mutated androgen receptor (AR) protein [<xref ref-type="bibr" rid="kennedy.REF.adachi.2005.659">Adachi et al 2005</xref>].</p>
          <p><bold>Androgen insensitivity.</bold> Symptoms of androgen insensitivity typically begin in adolescence with gynecomastia, which is observed frequently in affected males [<xref ref-type="bibr" rid="kennedy.REF.warner.1992.2181">Warner et al 1992</xref>, <xref ref-type="bibr" rid="kennedy.REF.sinnreich.2004.378">Sinnreich et al 2004</xref>]. Variability in disease severity and progression occurs both within and between families [<xref ref-type="bibr" rid="kennedy.REF.la_spada.1992.301">La Spada et al 1992</xref>, <xref ref-type="bibr" rid="kennedy.REF.doyu.1993.832">Doyu et al 1993</xref>, <xref ref-type="bibr" rid="kennedy.REF.lee.2005.57">Lee et al 2005</xref>]. This is especially true of the androgen insensitivity signs of testicular atrophy and oligospermia/azoospermia with reduced fertility (see <related-object link-type="booklink" source-id="gene" document-id="androgen" document-type="chapter">Androgen Insensitivity Syndrome</related-object>). Males with SBMA may not be able to grow a thick beard and may have difficulty conceiving.</p>
          <p>The androgen insensitivity can be of greater concern to affected individuals than the motor neuron disease, especially early in the course of the disorder [<xref ref-type="bibr" rid="kennedy.REF.warner.1992.2181">Warner et al 1992</xref>].</p>
          <sec id="kennedy.Heterozygotes">
            <title>Heterozygotes</title>
            <p><bold>Neurologic findings.</bold> Females who are carriers of full-penetrance alleles of greater than 38 CAG repeats in <italic toggle="yes">AR</italic> are usually asymptomatic. While number of carriers have experienced muscle cramps or occasional tremors, female carriers usually do not have significant motor neuron disease [<xref ref-type="bibr" rid="kennedy.REF.nance.1997.881">Nance 1997</xref>, <xref ref-type="bibr" rid="kennedy.REF.mariotti.2000.391">Mariotti et al 2000</xref>].</p>
            <p>Females who are symptomatic may have an abnormal electromyography [<xref ref-type="bibr" rid="kennedy.REF.sobue.1993.74">Sobue et al 1993</xref>].</p>
            <p><bold>Androgen insensitivity.</bold> SBMA is a sex-limited disorder, with females protected by having low levels of circulating androgens leading to lower levels of androgen receptor stimulation. In addition, due to X-chromosome inactivation, females have only a portion of actively transcribed full-penetrance alleles (CAG&#x0003e;37), but it is the low level of circulating androgen that likely accounts for limited to absent symptoms in heterozygous female carriers or in females with biallelic full-penetrance <italic toggle="yes">AR</italic> alleles.</p>
          </sec>
        </sec>
        <sec id="kennedy.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Studies of the number of CAG repeats in <italic toggle="yes">AR</italic> alleles in males with SBMA have established a correlation between number of CAG repeats and disease severity. In general, CAG repeat number inversely correlates with the age of onset of muscle weakness, difficulty climbing stairs, and wheelchair dependence [<xref ref-type="bibr" rid="kennedy.REF.la_spada.1992.301">La Spada et al 1992</xref>]. Thus, males with SBMA whose alleles have a larger number of CAG repeats tend to have earlier disease onset and more rapid progression [<xref ref-type="bibr" rid="kennedy.REF.doyu.1992.707">Doyu et al 1992</xref>, <xref ref-type="bibr" rid="kennedy.REF.igarashi.1992.2300">Igarashi et al 1992</xref>]. For example, early onset (age 8-15 years) and rapid progression have been described in a family in which affected individuals have alleles of 50-54 CAG repeats [<xref ref-type="bibr" rid="kennedy.REF.echanizlaguna.2005.1458">Echaniz-Laguna et al 2005</xref>].</p>
          <p>However, these correlations are only generalizations and exceptions have been reported. For example, a male in a family with SBMA with <italic toggle="yes">AR</italic> alleles of 37 CAG repeats (the average number of repeats in affected males) has been reported to be asymptomatic at age 46 years [<xref ref-type="bibr" rid="kennedy.REF.kuhlenb_umer.2001.23">Kuhlenb&#x000e4;umer et al 2001</xref>]. The largest <italic toggle="yes">AR</italic> repeat expansion reported in a person with SBMA is 68 [<xref ref-type="bibr" rid="kennedy.REF.grunseich.2014a.978">Grunseich et al 2014a</xref>].</p>
          <p>The genotype-phenotype correlation between allelic CAG repeat number and disease severity can only account for about 60% of the variability observed in clinical findings, indicating that other factors in addition to CAG repeat number determine age of disease onset and rate of disease progression. Indeed, relatives with SBMA with an identical CAG repeat number may have considerably different disease courses.</p>
        </sec>
        <sec id="kennedy.Nomenclature">
          <title>Nomenclature</title>
          <p>In the past, SBMA has been called X-linked spinal muscular atrophy.</p>
        </sec>
        <sec id="kennedy.Prevalence">
          <title>Prevalence</title>
          <p>SBMA has an estimated prevalence of 1:300,000 males. It only occurs in individuals of European or Asian racial background; it has yet to be reported in individuals of African or aboriginal racial background.</p>
          <p>European populations in which SBMA has been observed include English, Belgian, French, Italian, German, Polish, Spanish, Swiss, Moroccan, and Turkish [<xref ref-type="bibr" rid="kennedy.REF.la_spada.1991.77">La Spada et al 1991</xref>]. A founder effect has been reported in Scandinavia [<xref ref-type="bibr" rid="kennedy.REF.lund.2000.631">Lund et al 2000</xref>].</p>
          <p>Asian populations in which SBMA has been observed include Chinese, Japanese, Korean, and Vietnamese. SBMA is much more common in the Japanese population than in other ethnic groups because of a founder effect [<xref ref-type="bibr" rid="kennedy.REF.tanaka.1996.1253">Tanaka et al 1996</xref>].</p>
        </sec>
      </sec>
      <sec id="kennedy.Genetically_Related_Allelic_Diso">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Other pathogenic variants in <italic toggle="yes">AR</italic> cause <related-object link-type="booklink" source-id="gene" document-id="androgen" document-type="chapter">androgen insensitivity syndrome</related-object>.</p>
      </sec>
      <sec id="kennedy.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>A number of hereditary and acquired neuromuscular disorders can produce gradually progressive muscle weakness.</p>
        <p>The disorder with which spinal and bulbar muscular atrophy (SBMA) is most often confused is <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">amyotrophic lateral sclerosis</related-object> (ALS). Probably about one in 25 individuals diagnosed with ALS actually has SBMA instead of ALS [<xref ref-type="bibr" rid="kennedy.REF.parboosingh.1997.568">Parboosingh et al 1997</xref>]. Differentiation of ALS from SBMA can usually be made based on history and physical examination. ALS involves upper as well as lower motor neurons; individuals with ALS usually display upper motor neuron signs including hyperreflexia and spasticity. Individuals with ALS typically show involvement of a wider range of muscle groups as well as a more rapid disease progression. An important feature of SBMA is androgen insensitivity, which often causes gynecomastia; thus evaluation of males with motor neuron disease should include an assessment of breast size to determine if gynecomastia is present [<xref ref-type="bibr" rid="kennedy.REF.nagashima.1988.141">Nagashima et al 1988</xref>].</p>
        <p>Other forms of spinal muscular atrophy (SMA) that show autosomal recessive, autosomal dominant, and even X-linked inheritance have been described [<xref ref-type="bibr" rid="kennedy.REF.zerres.1989.85">Zerres 1989</xref>]. Of these, autosomal recessive <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">SMA</related-object> is the most common, occurring as five different phenotypes based on age of onset and maximum function attained. Types 0-III are known respectively as congenital SMA, Werdnig-Hoffman disease (acute), Dubowitz disease (chronic), and Kugelberg-Welander disease; all four types present in infancy or childhood, allowing clear differentiation from SBMA. Type IV SMA, like SBMA, has adult onset, but is much rarer than types 0-III.</p>
        <p>Muscle atrophy and muscle weakness from loss of motor neurons in the spinal cord are seen in other inherited neurodegenerative disorders including <related-object link-type="booklink" source-id="gene" document-id="sca3" document-type="chapter">spinocerebellar ataxia type 3</related-object> (SCA3 or Machado-Joseph disease), <related-object link-type="booklink" source-id="gene" document-id="friedreich" document-type="chapter">Friedreich ataxia</related-object> (FRDA), <related-object link-type="booklink" source-id="gene" document-id="tay-sachs" document-type="chapter">Tay-Sachs disease</related-object>, and the adrenomyeloneuropathy (AMN) variant of <related-object link-type="booklink" source-id="gene" document-id="x-ald" document-type="chapter">X-linked adrenoleukodystrophy</related-object> (X-ALD); however, these disorders are quite different from SBMA. Individuals with prominent sensory findings in addition to muscle weakness could have a peripheral neuropathy (see <related-object link-type="booklink" source-id="gene" document-id="cmt" document-type="chapter">Charcot-Marie-Tooth Hereditary Neuropathy Overview</related-object>).</p>
        <p>Non-genetic causes for motor neuron disease include structural lesions (e.g., spinal cord arteriovenous malformations), infections (especially poliomyelitis), toxins (chronic lead poisoning), metabolic problems (thyrotoxicosis), and paraneoplastic syndromes. Individuals with SBMA have been misdiagnosed as having chronic inflammatory neuropathy, metabolic myopathy, polymyositis, and myasthenia gravis.</p>
      </sec>
      <sec id="kennedy.Management">
        <title>Management</title>
        <sec id="kennedy.Evaluations_Following_Initial_Di">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with spinal and bulbar muscular atrophy (SBMA), the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Assessment of/for:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Neurologic findings; attention to distal muscle strength and deep tendon reflexes</p>
                </list-item>
                <list-item>
                  <p>Speech</p>
                </list-item>
                <list-item>
                  <p>Swallowing</p>
                </list-item>
                <list-item>
                  <p>Androgen responsiveness: male pattern hair growth, testicular size, and fertility</p>
                </list-item>
                <list-item>
                  <p>Gynecomastia</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="kennedy.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Physical therapy and rehabilitation approaches, including the use of braces and walkers, offer the best prospect for remaining ambulatory as the disease progresses.</p>
          <p>Some individuals with SBMA have breast reduction surgery for gynecomastia [<xref ref-type="bibr" rid="kennedy.REF.sperfeld.2002.1921">Sperfeld et al 2002</xref>].</p>
        </sec>
        <sec id="kennedy.Prevention_of_Primary_Manifestat">
          <title>Prevention of Primary Manifestations</title>
          <p>There are currently no effective treatments to prevent development of disease manifestations in an asymptomatic individual known to possess an expanded CAG repeat after presymptomatic diagnosis.</p>
        </sec>
        <sec id="kennedy.Prevention_of_Secondary_Complica">
          <title>Prevention of Secondary Complications</title>
          <p>The most worrisome complications in SBMA result from bulbar weakness, as these complications (asphyxiation and aspiration pneumonia) can be life threatening. Individuals with bulbar weakness must be counseled in the importance of carefully cutting their food into small pieces for eating and avoiding items that may be difficult to chew and then swallow.</p>
        </sec>
        <sec id="kennedy.Surveillance">
          <title>Surveillance</title>
          <p>Appropriate measures include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Strength testing (annually)</p>
            </list-item>
            <list-item>
              <p>Pulmonary function tests (annually in advanced cases)</p>
            </list-item>
          </list>
        </sec>
        <sec id="kennedy.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Individuals with a tendency to fall should avoid slippery or rough walking surfaces.</p>
        </sec>
        <sec id="kennedy.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="kennedy.Related_Genetic_Counseling_Issue">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="kennedy.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p><bold>High-dose testosterone.</bold> At least one clinical trial of high-dose oral testosterone has been undertaken; no significant benefit was derived for the androgen treatment group [<xref ref-type="bibr" rid="kennedy.REF.goldenberg.1996.158">Goldenberg &#x00026; Bradley 1996</xref>]. Based on research in <italic toggle="yes">Drosophila</italic> and mouse models of SBMA, many investigators believe that androgen treatment can be harmful.</p>
          <p><bold>Anti-androgen therapy.</bold> There is no consensus or clear evidence as to whether anti-androgen therapy is an effective form of treatment for the neurologic complications.</p>
          <list list-type="bullet">
            <list-item>
              <p>Anti-androgen therapy shows promise based on studies in <italic toggle="yes">Drosophila</italic> and mouse models as well as knowledge of the molecular basis of SBMA. For these reasons, a Japanese group [<xref ref-type="bibr" rid="kennedy.REF.banno.2009.140">Banno et al 2009</xref>] performed a clinical trial of leuprorelin in individuals with SBMA who were followed over 48 weeks: significant improvement was observed in cricopharyngeal opening duration, but in no other outcome measures. In particular, there was no effect on the primary outcome measure (the ALS Functional Rating Scale or ALSFRS) in the period of randomization. Although the trial was continued as an open label extension, and encouraging results were reported, the conclusion was that this clinical trial did not establish efficacy for anti-androgen therapy in SBMA [<xref ref-type="bibr" rid="kennedy.REF.fischbeck.2009.119">Fischbeck &#x00026; Bryan 2009</xref>].</p>
            </list-item>
            <list-item>
              <p>A larger subsequent study with swallow function as the primary outcome measure also did not show an overall benefit, except in post hoc analysis of subjects in whom disease duration was less than ten years [<xref ref-type="bibr" rid="kennedy.REF.katsuno.2010.875">Katsuno et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Another anti-androgen therapy approach was attempted [<xref ref-type="bibr" rid="kennedy.REF.fern_ndezrhodes.2011.140">Fern&#x000e1;ndez-Rhodes et al 2011</xref>]: individuals with SBMA were randomized to placebo or dutasteride, a drug that blocks the conversion of testosterone to dihydrotestosterone (DHT). The rationale was that DHT may mediate many of the toxic effects, and this drug would permit affected individuals to retain the anabolic effects of testosterone, thereby diminishing the side effects of anti-androgen therapy. However, this study did not show a significant effect of dutasteride on the progression of muscle weakness in SBMA.</p>
            </list-item>
          </list>
          <p>Hence, the utility of anti-androgen therapy as a treatment for SBMA remains unclear. Furthermore, it is possible that anti-androgen therapies, even if effective, would need to be administered prior to disease onset or early on in the neurodegenerative process. More importantly, the side effects of anti-androgen therapies would probably far outweigh the therapeutic benefit for most individuals, and likely should be reserved for people with SBMA who are wheelchair bound or exhibit pronounced bulbar weakness.</p>
          <p><bold>Creatine supplementation.</bold> Studies of <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">amyotrophic lateral sclerosis</related-object> (ALS) suggest that creatine supplementation may temporarily enhance muscle strength and exercise performance in this motor neuron disease [<xref ref-type="bibr" rid="kennedy.REF.mazzini.2001.139">Mazzini et al 2001</xref>], prompting speculation that it may offer a similar benefit to individuals with SBMA; this remains to be tested.</p>
          <p>
            <bold>Experimental therapies in animal models</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Other interventions that have been shown to have benefit in mouse models of SBMA include the HSP-90 inhibitors 17-AAG and 17-DMAG, the synthetic curcumin derivative ASC-J9, and insulin-like growth factor 1 (reviewed in <xref ref-type="bibr" rid="kennedy.REF.fischbeck.2012.257">Fischbeck [2012]</xref>).</p>
            </list-item>
            <list-item>
              <p>More recently, one group directly examined the role of muscle expression of mutated AR in SBMA disease pathogenesis by developing a BAC transgenic mouse model featuring a floxed first exon to permit cell-type specific excision of a human <italic toggle="yes">AR</italic> transgene [<xref ref-type="bibr" rid="kennedy.REF.cortes.2014.295">Cortes et al 2014</xref>]. They engineered the human <italic toggle="yes">AR</italic> transgene to carry 121 CAG repeats (BAC fxAR121), and found that BAC fxAR121 mice develop a gender-restricted, progressive neuromuscular phenotype, characterized by weight loss, motor deficits, muscle atrophy, myopathy, and shortened life span. By terminating expression of mutated AR in the skeletal muscles of BAC fxAR121 male mice, this study revealed a crucial role for muscle expression of mutated AR in SBMA disease pathogenesis. Hence, this work predicts that muscle-directed therapies hold great promise as definitive treatments for SBMA motor neuron degeneration.</p>
            </list-item>
            <list-item>
              <p>Another study sought to ameliorate toxicity in mouse models of SBMA by suppressing polyQ-AR expression using antisense oligonucleotides (ASOs) [<xref ref-type="bibr" rid="kennedy.REF.lieberman.2014.774">Lieberman et al 2014</xref>]. This investigation developed compounds to specifically target <italic toggle="yes">AR</italic> expression in the periphery, and using two mouse models, found that peripheral gene suppression of mutated AR rescues deficits in muscle weight, fiber size, and grip strength; reverses changes in muscle gene expression; and extends the life span of mutant males. Interestingly, delivery of an anti-AR ASO to the CNS also elicited a modest improvement in these disease read-outs in a SBMA mouse model, but was much less effective than peripheral delivery. Hence, this report, together with the genetic rescue study of SBMA [<xref ref-type="bibr" rid="kennedy.REF.cortes.2014.295">Cortes et al 2014</xref>], strongly suggests that peripheral administration of therapies directed to muscle should be explored in humans with SBMA. Preparations are underway to initiate a clinical trial of anti-AR ASO therapy via peripheral delivery in males with SBMA.</p>
            </list-item>
          </list>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="kennedy.Other">
          <title>Other</title>
          <p>Administration of male hormones (testosterone and its analogs) is not effective in overcoming the androgen insensitivity.</p>
        </sec>
      </sec>
      <sec id="kennedy.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="kennedy.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Spinal and bulbar muscular atrophy (SBMA) is inherited in an X-linked manner.</p>
        </sec>
        <sec id="kennedy.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a male proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have the disorder nor will he be hemizygous for a pathogenic CAG trinucleotide expansion in <italic toggle="yes">AR</italic>; therefore, he does not require further evaluation/testing.</p>
            </list-item>
            <list-item>
              <p>To date, all mothers of men with SBMA who have been tested have been shown to carry one <italic toggle="yes">AR</italic> allele with an abnormal number of CAG repeats. However, SBMA is a late-onset disorder and mothers may not always be available for testing.</p>
            </list-item>
            <list-item>
              <p>The true incidence of <italic toggle="yes">de novo</italic> CAG trinucleotide expansion in men with SBMA is not presently known; no <italic toggle="yes">de novo</italic> expansions have been observed thus far.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a male proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the genetic status of the mother.</p>
            </list-item>
            <list-item>
              <p>Based on the observation that all tested mothers of affected males are heterozygotes (carriers), the chance of transmitting the pathogenic CAG trinucleotide expansion in each pregnancy is 50%.</p>
            </list-item>
            <list-item>
              <p>Male sibs who inherit the pathogenic CAG trinucleotide expansion will be affected; female sibs who inherit the expansion will be heterozygotes (carriers) and will usually not be affected.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a male proband.</bold> Affected males transmit the pathogenic CAG trinucleotide expansion to:</p>
          <list list-type="bullet">
            <list-item>
              <p>All of their daughters who will be heterozygotes (carriers) and will usually not be affected;</p>
            </list-item>
            <list-item>
              <p>None of their sons.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> The proband's maternal aunts may be at risk of being heterozygotes (carriers) for the pathogenic CAG trinucleotide expansion and the aunt's offspring, depending on their gender, may be at risk of being carriers or of being affected.</p>
        </sec>
        <sec id="kennedy.Heterozygote_Carrier_Detection">
          <title>Heterozygote (Carrier) Detection</title>
          <p>Once the <italic toggle="yes">AR</italic> CAG repeat expansion has been identified in an affected family member, carrier testing of at-risk female relatives is possible.</p>
          <p>Note: Females who are heterozygous (carriers) for this X-linked disorder will usually not be affected.</p>
        </sec>
        <sec id="kennedy.Related_Genetic_Counseling_Issue">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>CAG repeat instability.</bold> Pathogenic <italic toggle="yes">AR</italic> alleles with abnormally large numbers of CAG repeats have the property of genetic instability, meaning that the number of CAG repeats often changes when transmitted from parent to offspring. In SBMA, a slight tendency toward expansion (an increase in number) of CAG repeats exists, although the number of CAG repeats is relatively stable with only small increases in repeat length and frequent small decreases in repeat number (i.e., contractions). Repeat instability with male transmission of a pathogenic allele has been described. Although a correlation exists between CAG repeat number and disease onset and severity in individuals with SBMA, prediction of disease course <bold>cannot</bold> be based on measured CAG repeat number.</p>
          <p><bold>Testing of at-risk asymptomatic adult relatives</bold> of individuals with SBMA is possible after molecular genetic testing has identified a pathogenic CAG trinucleotide expansion in an affected family member. Such testing is not useful in accurately predicting age of onset, severity, type of symptoms, or rate of disease progression in asymptomatic individuals.</p>
          <p><bold>Molecular genetic testing of asymptomatic individuals younger than age 18 years</bold> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p>
          <p>It is appropriate to consider testing symptomatic individuals regardless of age in a family with an established diagnosis of SBMA.</p>
          <p>For more information, see also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="kennedy.Prenatal_Testing_and_Preimplanta">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once a pathogenic CAG trinucleotide expansion in <italic toggle="yes">AR</italic> has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for SBMA are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="kennedy.Resources">
        <title>Resources</title>
      </sec>
      <sec id="kennedy.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">AR</italic> comprises eight exons and spans 180 kb [UCSC Genome Browser]. The longest transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000044.3">NM_000044.3</ext-link> has 10,661 bp with a coding region of 2,763 bp. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="kennedy" object-id="kennedy.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign variants.</bold> A highly polymorphic CAG repeat starting at amino acid codon number 58 is found within the AR coding domain. Unaffected individuals have five to 34 CAG trinucleotide repeats; some may have reduced-penetrance alleles with 36-37 repeats (see <xref ref-type="sec" rid="kennedy.Establishing_the_Diagnosis">Establishing the Diagnosis</xref>).</p>
        <p>About 98% of females are heterozygous and have <italic toggle="yes">AR</italic> alleles with different numbers of CAG repeats on their two X chromosomes. The most common alleles number from 18 to 25 CAG repeats. Variation in mean CAG repeat length occurs within different racial populations, with Africans having the smallest mean CAG repeat length and Asians having the largest mean CAG repeat length; the CAG repeat length in white European populations is intermediate to these two.</p>
        <p>The high degree of heterozygosity in females makes the <italic toggle="yes">AR</italic> CAG repeat a useful marker for studying X-chromosome inactivation.</p>
        <p><bold>Pathogenic variants.</bold> Expansion beyond the normal range of CAG trinucleotide repeat within the coding region of <italic toggle="yes">AR</italic> causes the spinal bulbar muscular atrophy (SBMA) phenotype [<xref ref-type="bibr" rid="kennedy.REF.la_spada.1991.77">La Spada et al 1991</xref>].</p>
        <p>Genetic testing of sperm of an affected male showed that 20% of the sperm had a CAG repeat number equal to that in the DNA from somatic cells, whereas 56% had further expansion of the CAG repeat number, and 24% had contraction of the CAG repeat number. Most of the allelic expansions and contractions were between one and three CAG repeats. Similar studies on oocytes have not been possible.</p>
        <table-wrap id="kennedy.T.selected_ar_variants" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Selected <italic toggle="yes">AR</italic> Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_kennedy.T.selected_ar_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                <th id="hd_h_kennedy.T.selected_ar_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_kennedy.T.selected_ar_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_kennedy.T.selected_ar_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Benign</bold>
                </td>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.172_174CAG(7_34)<break/>(CAG ?-34 repeats)</td>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote&#x000a0;1</td>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_4" rowspan="4" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000044.3">NM_000044.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000035.2">NP_000035.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Unknown</bold>
                </td>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.172_174CAG(35)<break/>(CAG 35 repeats)</td>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote&#x000a0;1</td>
              </tr>
              <tr>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Reduced-penetrance allele</bold>
                </td>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.172_174CAG(36_37)<break/>(CAG 36-37 repeats)</td>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote&#x000a0;1</td>
              </tr>
              <tr>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Pathogenic</bold>
                </td>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.172_174CAG(38_68)<break/>(CAG 38-? repeats)</td>
                <td headers="hd_h_kennedy.T.selected_ar_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote&#x000a0;1</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="kennedy.TF.2.1">
              <label>1. </label>
              <p>Each CAG repeat results in the addition of a glutamine residue to the polymorphic polyglutamine repeat.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">AR</italic> is a member of the steroid receptor superfamily and therefore displays a typical protein structure, consisting of a highly conserved DNA-binding domain at the center of the protein and a highly conserved ligand-binding domain at the C-terminal end. <italic toggle="yes">AR</italic> transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000044.3">NM_000044.3</ext-link> encodes a 920-amino acid protein with molecular mass of approximately 110 kd. A second isoform of approximately 87 kd is found in most cell types and likely reflects translation initiation at p.Met188 of the full-length protein [<xref ref-type="bibr" rid="kennedy.REF.gao.1998.654">Gao &#x00026; McPhaul 1998</xref>]. The N-terminal region of the androgen receptor (AR) protein is relatively poorly conserved and is thought to mediate transcriptional activation of target genes [<xref ref-type="bibr" rid="kennedy.REF.zhou.1995.208">Zhou et al 1995</xref>]. The AR protein contains a nuclear localization signal (NLS) at amino acids 627-658.</p>
        <p><bold>Abnormal gene product.</bold> CAG encodes the amino acid glutamine, therefore, CAG expansions produce an AR protein with an abnormally long polyglutamine stretch at the N-terminal end [<xref ref-type="bibr" rid="kennedy.REF.la_spada.1991.77">La Spada et al 1991</xref>]. This expanded polyglutamine tract presumably alters the conformation of the AR protein (or an N-terminal peptide fragment from the AR protein) resulting in neurodegeneration in SBMA via a gain-of-function mechanism. The AR protein is expressed in the brain, spinal cord, and muscle [<xref ref-type="bibr" rid="kennedy.REF.matsuura.1993.5">Matsuura et al 1993</xref>, <xref ref-type="bibr" rid="kennedy.REF.ogata.1994.1274">Ogata et al 1994</xref>].</p>
        <p>SBMA and other CAG trinucleotide expansion diseases involving the central nervous system result from the abnormal glutamine expansion in the protein [<xref ref-type="bibr" rid="kennedy.REF.la_spada.2010.247">La Spada &#x00026; Taylor 2010</xref>]. Genes associated with these so-called "polyglutamine tract expansion diseases" produce unrelated proteins. How polyglutamine tract expansion leads to neurodegeneration in SBMA and these other diseases is still unknown [<xref ref-type="bibr" rid="kennedy.REF.la_spada.2010.247">La Spada &#x00026; Taylor 2010</xref>]. One possible pathogenic cascade posits that the polyglutamine tract region is proteolytically processed and a polyglutamine-containing peptide fragment is retained in the nucleus, where it forms neuronal intranuclear inclusions (NIIs) [<xref ref-type="bibr" rid="kennedy.REF.young.2009.1987">Young et al 2009</xref>]. Once in the nucleus, polyglutamine-expanded AR peptide fragments may cause pathology by interfering with transcriptional coactivators such as the CREB-binding protein [<xref ref-type="bibr" rid="kennedy.REF.mccampbell.2000.2197">McCampbell et al 2000</xref>, <xref ref-type="bibr" rid="kennedy.REF.sopher.2004.687">Sopher et al 2004</xref>]. NIIs have been found in spinal cord sections from deceased individuals with SBMA [<xref ref-type="bibr" rid="kennedy.REF.li.1998.249">Li et al 1998</xref>]. In addition to gain-of-function polyglutamine proteotoxicity, recent research work has focused on the role of altered normal function in dictating cell type specificity in SBMA, and this work suggests that altered protein complex interactions between AR and its coactivators and corepressors may underlie disease pathogenesis [<xref ref-type="bibr" rid="kennedy.REF.nedelsky.2010.936">Nedelsky et al 2010</xref>].</p>
        <p><bold>Cancer and benign tumors.</bold> Dozens of epidemiologic and genetic association studies have examined a potential inverse relationship between AR CAG repeat length and the risk of developing prostate cancer. In 2013, a meta-analysis of published data up to that time concluded that &#x0201c;a shorter CAG repeat polymorphism may increase the risk of prostate cancer compared with the longer CAG repeat; in particular, the effect of shorter CAG repeats on the increased risk of prostate cancer was predominantly observed in Caucasians [<italic toggle="yes">i.e., persons of northern European background</italic> &#x02013;ED.] and Asians&#x0201d; [<xref ref-type="bibr" rid="kennedy.REF.sun.2013.1195">Sun &#x00026; Lee 2013</xref>].</p>
      </sec>
      <sec id="kennedy.References">
        <title>References</title>
        <sec id="kennedy.Published_GuidelinesConsensus_St">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="kennedy.Published_GuidelinesConsensus_St.reflist0">
            <ref id="kennedy.REF1">
              <mixed-citation publication-type="web">American Society of Human Genetics and American College of Medical Genetics. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801355/pdf/ajhg00037-0249.pdf">online</ext-link>. 1995. Accessed 1-18-17</mixed-citation>
            </ref>
            <ref id="kennedy.REF2">
              <mixed-citation publication-type="web">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 1-18-17</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="kennedy.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="kennedy.Literature_Cited.reflist0">
            <ref id="kennedy.REF.adachi.2005.659">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Adachi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsuno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minamiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagomi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doyu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inukai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashizume</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients.</article-title>
                <source>Brain.</source>
                <volume>128</volume>
                <fpage>659</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">15659427</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.amato.1993.791">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amato</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barohn</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snyder</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papp</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendell</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene.</article-title>
                <source>Neurology.</source>
                <volume>43</volume>
                <fpage>791</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">8469342</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.antonini.2000.252">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Antonini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gragnani</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romaniello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pennisi</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceschin</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santoro</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruccu</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Sensory involvement in spinal-bulbar muscular atrophy (Kennedy's disease).</article-title>
                <source>Muscle Nerve.</source>
                <volume>23</volume>
                <fpage>252</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10639619</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.atsuta.2006.1446">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Atsuta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banno</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsuno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamakoshi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients.</article-title>
                <source>Brain.</source>
                <volume>129</volume>
                <fpage>1446</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">16621916</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.banno.2009.140">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Banno</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsuno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeuchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawashima</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suga</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takamori</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adachi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minamiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atsuta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakashima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doyu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.</article-title>
                <source>Ann Neurol.</source>
                <year>2009</year>
                <volume>65</volume>
                <fpage>140</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">19259967</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.cortes.2014.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cortes</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ling</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>LT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hung</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsunemi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ly</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tokunaga</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sopher</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shelton</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleveland</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Spada</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy.</article-title>
                <source>Neuron.</source>
                <year>2014</year>
                <volume>82</volume>
                <fpage>295</fpage>
                <lpage>307</lpage>
                <pub-id pub-id-type="pmid">24742458</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.doyu.1993.832">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Doyu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsuma</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwase</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Very late onset X-linked recessive bulbospinal neuronopathy: mild clinical features and a mild increase in the size of tandem CAG repeat in androgen receptor gene.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <volume>56</volume>
                <fpage>832</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">8331366</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.doyu.1992.707">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Doyu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukai</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsuma</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene.</article-title>
                <source>Ann Neurol.</source>
                <volume>32</volume>
                <fpage>707</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">1449253</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.echanizlaguna.2005.1458">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Echaniz-Laguna</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rousso</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anheim</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coss&#x000e9;e</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranchant</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A family with early-onset and rapidly progressive X-linked spinal and bulbar muscular atrophy.</article-title>
                <source>Neurology.</source>
                <volume>64</volume>
                <fpage>1458</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">15851746</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.fern_ndezrhodes.2011.140">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez-Rhodes</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kokkinis</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeffries</surname>
                    <given-names>NO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shrader</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehky</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryder</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solomon</surname>
                    <given-names>BI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris-Love</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Pean</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Prospero</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.</article-title>
                <source>Lancet Neurol.</source>
                <volume>10</volume>
                <fpage>140</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21216197</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.ferrante.1997.323">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferrante</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilbourn</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>The characteristic electrodiagnostic features of Kennedy's disease.</article-title>
                <source>Muscle Nerve.</source>
                <volume>20</volume>
                <fpage>323</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9052811</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.fischbeck.2009.119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bryan</surname>
                    <given-names>WW</given-names>
                  </name>
                </person-group>
                <article-title>Anti-androgen treatment for spinal and bulbar muscular atrophy.</article-title>
                <source>Ann Neurol.</source>
                <year>2009</year>
                <volume>65</volume>
                <fpage>119</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">19259961</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.fischbeck.2012.257">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Developing treatment for spinal and bulbar muscular atrophy.</article-title>
                <source>Prog Neurobiol.</source>
                <year>2012</year>
                <volume>99</volume>
                <fpage>257</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">22668795</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.gao.1998.654">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McPhaul</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Functional activities of the A and B forms of the human androgen receptor in response to androgen receptor agonists and antagonists.</article-title>
                <source>Mol Endocrinol.</source>
                <volume>12</volume>
                <fpage>654</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">9605928</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.goldenberg.1996.158">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldenberg</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>WG</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Testosterone therapy and the pathogenesis of Kennedy's disease (X-linked bulbospinal muscular atrophy).</article-title>
                <source>J Neurol Sci.</source>
                <volume>135</volume>
                <fpage>158</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">8867072</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.grunseich.2014a.978">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grunseich</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kats</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bott</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kokkinis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mankodi</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shrader</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehky</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2014a</year>
                <volume>24</volume>
                <fpage>978</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">25047668</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.grunseich.2014b.6">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grunseich</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Spinal and bulbar muscular atrophy: pathogenesis and clinical management.</article-title>
                <source>Oral Dis.</source>
                <year>2014b</year>
                <volume>20</volume>
                <fpage>6</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23656576</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.harding.1982.1012">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baraitser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradbury</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan-Hughes</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponsford</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>1982</year>
                <article-title>X-linked recessive bulbospinal neuronopathy: a report of ten cases.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <volume>45</volume>
                <fpage>1012</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">6890989</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.igarashi.1992.2300">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanno</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamazaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishikawa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyatani</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagashima</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishikawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>1992</year>
                <article-title>Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy.</article-title>
                <source>Neurology.</source>
                <volume>42</volume>
                <fpage>2300</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">1461383</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.katsuno.2010.875">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Katsuno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banno</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeuchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawashima</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yabe</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishikawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizusawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimohata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyajima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanda</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakashima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsujino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                  <collab>Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group</collab>
                </person-group>
                <article-title>Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial.</article-title>
                <source>Lancet Neurol.</source>
                <year>2010</year>
                <volume>9</volume>
                <fpage>875</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">20691641</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.kennedy.1968.671">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sung</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>1968</year>
                <article-title>Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait.</article-title>
                <source>Neurology.</source>
                <volume>18</volume>
                <fpage>671</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">4233749</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.kuhlenb_umer.2001.23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kuhlenb&#x000e4;umer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringelstein</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000f6;gbauer</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Thirty-seven CAG repeats in the androgen receptor gene in two healthy individuals.</article-title>
                <source>J Neurol.</source>
                <volume>248</volume>
                <fpage>23</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11266016</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.la_spada.1992.301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>La Spada</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roling</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warner</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spiegel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hausmanowa-Petrusewicz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yee</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy.</article-title>
                <source>Nat Genet.</source>
                <volume>2</volume>
                <fpage>301</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">1303283</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.la_spada.1991.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>La Spada</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubahn</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.</article-title>
                <source>Nature.</source>
                <volume>352</volume>
                <fpage>77</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">2062380</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.la_spada.2010.247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>La Spada</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Repeat expansion disease: progress and puzzles in disease pathogenesis.</article-title>
                <source>Nat Rev Genet.</source>
                <year>2010</year>
                <volume>11</volume>
                <fpage>247</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">20177426</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.lee.2005.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Phenotypic variability in Kennedy's disease: implication of the early diagnostic features.</article-title>
                <source>Acta Neurol Scand.</source>
                <volume>112</volume>
                <fpage>57</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">15932358</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.li.1998.249">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miwa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merry</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doyu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashizume</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy.</article-title>
                <source>Ann Neurol.</source>
                <volume>44</volume>
                <fpage>249</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">9708548</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.lieberman.2014.774">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lieberman</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peralta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Low</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>XX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cortes</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monia</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Spada</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hung</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy.</article-title>
                <source>Cell Rep.</source>
                <year>2014</year>
                <volume>7</volume>
                <fpage>774</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">24746732</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.lund.2000.631">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juvonen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cederquist</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronnevi</surname>
                    <given-names>LO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistonen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000f6;rensen</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranebjaerg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savontaus</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia.</article-title>
                <source>Eur J Hum Genet.</source>
                <volume>8</volume>
                <fpage>631</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10951525</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.mariotti.2000.391">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mariotti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castellotti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pareyson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Testa</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antozzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silani</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tezzon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siciliano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gellera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donato</surname>
                    <given-names>SD</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>10</volume>
                <fpage>391</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10899444</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.matsuura.1993.5">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsuura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogata</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriwaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tashiro</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koyanagi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagashima</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Identification of androgen receptor in the rat spinal motoneurons. Immunohistochemical and immunoblotting analyses with monoclonal antibody.</article-title>
                <source>Neurosci Lett.</source>
                <volume>158</volume>
                <fpage>5</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8233073</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.mazzini.2001.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mazzini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balzarini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colombo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mora</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pastore</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Ambrogio</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caligari</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results.</article-title>
                <source>J Neurol Sci.</source>
                <volume>191</volume>
                <fpage>139</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">11677005</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.mccampbell.2000.2197">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McCampbell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taye</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robitschek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walcott</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merry</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paulson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>CREB-binding protein sequestration by expanded polyglutamine.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2000</year>
                <volume>9</volume>
                <fpage>2197</fpage>
                <lpage>202</lpage>
                <pub-id pub-id-type="pmid">10958659</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.nagashima.1988.141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nagashima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seko</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arima</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagashima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morimatsu</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Familial bulbo-spinal muscular atrophy associated with testicular atrophy and sensory neuropathy (Kennedy-Alter-Sung syndrome). Autopsy case report of two brothers.</article-title>
                <source>J Neurol Sci.</source>
                <volume>87</volume>
                <fpage>141</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">3210030</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.nance.1997.881">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nance</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Clinical aspects of CAG repeat diseases.</article-title>
                <source>Brain Pathol.</source>
                <volume>7</volume>
                <fpage>881</fpage>
                <lpage>900</lpage>
                <pub-id pub-id-type="pmid">9217974</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.nedelsky.2010.936">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nedelsky</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pennuto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palazzolo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nie</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neale</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy.</article-title>
                <source>Neuron.</source>
                <year>2010</year>
                <volume>67</volume>
                <fpage>936</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">20869592</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.ogata.1994.1274">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ogata</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tashiro</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriwaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koyanagi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagashima</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Expression of androgen receptor in X-linked spinal and bulbar muscular atrophy and amyotrophic lateral sclerosis.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <volume>57</volume>
                <fpage>1274</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">7931399</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.olney.1991.823">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Olney</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aminoff</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>So</surname>
                    <given-names>YT</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Clinical and electrodiagnostic features of X-linked recessive bulbospinal neuronopathy.</article-title>
                <source>Neurology.</source>
                <volume>41</volume>
                <fpage>823</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">2046924</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.parboosingh.1997.568">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parboosingh</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figlewicz</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krizus</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meininger</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azad</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS.</article-title>
                <source>Neurology.</source>
                <volume>49</volume>
                <fpage>568</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">9270598</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.rhodes.2009.3242">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rhodes</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kokkinis</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Pean</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehky</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shrader</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris-Love</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Prospero</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Clinical features of spinal and bulbar muscular atrophy.</article-title>
                <source>Brain.</source>
                <year>2009</year>
                <volume>132</volume>
                <fpage>3242</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">19846582</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.sinnreich.2004.378">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sinnreich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorenson</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>CJ</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Neurologic course, endocrine dysfunction and triplet repeat size in spinal bulbar muscular atrophy.</article-title>
                <source>Can J Neurol Sci.</source>
                <volume>31</volume>
                <fpage>378</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">15376484</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.sobue.1993.74">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doyu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukai</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumagai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsuma</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy.</article-title>
                <source>J Neurol Sci.</source>
                <volume>117</volume>
                <fpage>74</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8410070</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.sopher.2004.687">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sopher</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>PS</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>LaFevre-Bernt</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holm</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilke</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ware</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Libby</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellerby</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Spada</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration.</article-title>
                <source>Neuron.</source>
                <year>2004</year>
                <volume>41</volume>
                <fpage>687</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">15003169</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.sorar_.2008.100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sorar&#x000f9;</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Ascenzo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmieri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baggio</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vergani</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gellera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moretto</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pegoraro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females.</article-title>
                <source>J Neurol Sci.</source>
                <year>2008</year>
                <volume>264</volume>
                <fpage>100</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17854832</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.sperfeld.2002.1921">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sperfeld</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karitzky</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brummer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schreiber</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;ussler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludolph</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanemann</surname>
                    <given-names>CO</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>X-linked bulbospinal neuronopathy: Kennedy disease.</article-title>
                <source>Arch Neurol.</source>
                <volume>59</volume>
                <fpage>1921</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12470181</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.sun.2013.1195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Association between CAG repeat polymorphisms and the risk of prostate cancer: a meta-analysis by race, study design and the number of (CAG)n repeat polymorphisms.</article-title>
                <source>Int J Mol Med.</source>
                <volume>32</volume>
                <fpage>1195</fpage>
                <lpage>203</lpage>
                <pub-id pub-id-type="pmid">23982466</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.tanaka.1996.1253">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doyu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsuma</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Founder effect in spinal and bulbar muscular atrophy (SBMA).</article-title>
                <source>Hum Mol Genet.</source>
                <volume>5</volume>
                <fpage>1253</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8872464</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.warner.1992.2181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Warner</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobs</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickoff</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griggs</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>X-linked spinomuscular atrophy: a kindred with associated abnormal androgen receptor binding.</article-title>
                <source>Neurology.</source>
                <volume>42</volume>
                <fpage>2181</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">1436532</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.young.2009.1987">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garden</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandoval</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sopher</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellerby</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Spada</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5/Hrk.</article-title>
                <source>J Neurosci.</source>
                <year>2009</year>
                <volume>29</volume>
                <fpage>1987</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">19228953</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.zerres.1989.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>Classification and genetics of proximal spinal muscular atrophies.</article-title>
                <source>Prog Clin Biol Res.</source>
                <year>1989</year>
                <volume>306</volume>
                <fpage>85</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">2662215</pub-id>
              </element-citation>
            </ref>
            <ref id="kennedy.REF.zhou.1995.208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>ZX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>MV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kemppainen</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>French</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability.</article-title>
                <source>Mol Endocrinol.</source>
                <volume>9</volume>
                <fpage>208</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">7776971</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="kennedy.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="kennedy.Suggested_Reading.reflist0">
            <ref id="kennedy.REF.rees">
              <mixed-citation publication-type="book">Rees JL. Spinobulbar muscular atrophy. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID)</italic>. Chap 161. New York, NY: McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
            <ref id="kennedy.REF.sinnreich.2004.1324">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sinnreich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>CJ</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Bulbospinal muscular atrophy: Kennedy's disease.</article-title>
                <source>Arch Neurol.</source>
                <volume>61</volume>
                <fpage>1324</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15313856</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="kennedy.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="kennedy.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>26 January 2017 (ma) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 July 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>13 October 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>28 December 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>1 July 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>29 August 2002 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>26 February 1999 (pb) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>15 December 1998 (als) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
